ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Employee Related Liabilities
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Employee Related Liabilities of -$572.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $70.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$642.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$796.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was -$485.00K, a 197.19% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$5.32M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for fiscal 2024 was -$4.93M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for fiscal 2023 was -$6.14M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$7.49M, a 259.65% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 4 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$572.00K 10-Q · filed 2026-08-12 | -$1.37M derived: sum of 3 quarters · filed 2026-08-12 | -$1.85M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$642.00K 10-Q · filed 2026-05-12 | -$1.44M derived: sum of 2 quarters · filed 2026-05-12 | -$1.92M derived: sum of 3 quarters · filed 2026-05-12 | -$3.97M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.28M derived: sum of 2 quarters · filed 2026-03-16 | -$3.33M derived: sum of 3 quarters · filed 2026-08-12 | -$5.32M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.53M derived: sum of 2 quarters · filed 2026-08-12 | -$4.52M 10-Q · filed 2025-11-12 | -$5.70M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$4.04M 10-Q · filed 2026-08-12 | -$5.22M derived: sum of 3 quarters · filed 2026-08-12 | -$4.72M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$1.99M 10-Q · filed 2026-05-12 | -$3.17M derived: sum of 2 quarters · filed 2026-05-12 | -$2.67M derived: sum of 3 quarters · filed 2026-05-12 | -$1.11M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$680.00K derived: sum of 2 quarters · filed 2026-03-16 | $882.00K derived: sum of 3 quarters · filed 2026-03-16 | -$4.93M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.06M derived: sum of 2 quarters · filed 2025-11-12 | -$3.75M 10-Q · filed 2025-11-12 | -$6.66M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$4.25M 10-Q · filed 2025-08-11 | -$7.16M derived: sum of 3 quarters · filed 2025-08-11 | -$5.29M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$5.81M 10-Q · filed 2025-05-15 | -$8.72M derived: sum of 2 quarters · filed 2025-05-15 | -$6.85M derived: sum of 3 quarters · filed 2025-05-15 | -$3.21M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$1.04M derived: sum of 2 quarters · filed 2025-03-07 | $2.61M derived: sum of 3 quarters · filed 2025-03-07 | -$6.14M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.52M derived: sum of 2 quarters · filed 2024-11-12 | -$3.23M 10-Q · filed 2024-11-12 | -$3.17M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $3.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$5.10M 10-Q · filed 2024-08-12 | -$5.05M derived: sum of 3 quarters · filed 2024-08-12 | -$3.76M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$8.75M 10-Q · filed 2024-05-09 | -$8.69M derived: sum of 2 quarters · filed 2024-05-09 | -$7.40M derived: sum of 3 quarters · filed 2024-05-09 | -$7.47M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.34M derived: sum of 2 quarters · filed 2024-03-28 | $1.28M derived: sum of 3 quarters · filed 2024-03-28 | -$7.49M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.22M derived: sum of 2 quarters · filed 2023-11-01 | -$7.54M 10-Q · filed 2023-11-01 | -$1.53M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | -$64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$8.83M 10-Q · filed 2023-08-08 | -$2.82M derived: sum of 3 quarters · filed 2023-08-08 | $994.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$8.77M 10-Q · filed 2023-05-08 | -$2.76M derived: sum of 2 quarters · filed 2023-05-08 | $1.06M derived: sum of 3 quarters · filed 2023-05-08 | $3.60M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | $6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $9.83M derived: sum of 2 quarters · filed 2023-02-08 | $12.36M derived: sum of 3 quarters · filed 2023-02-08 | $4.69M 10-K · filed 2023-02-08 | |
| 2021-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $6.35M derived: sum of 2 quarters · filed 2022-11-08 | -$1.32M 10-Q · filed 2022-11-08 | $2.43M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$5.13M 10-Q · filed 2022-08-08 | -$1.39M derived: sum of 3 quarters · filed 2023-02-08 | $2.67M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-03-31 | -$7.67M 10-Q · filed 2022-05-05 | -$3.92M derived: sum of 2 quarters · filed 2023-02-08 | $129.00K derived: sum of 3 quarters · filed 2023-02-08 | $3.11M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2020-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $7.80M derived: sum of 2 quarters · filed 2023-02-08 | $10.78M derived: sum of 3 quarters · filed 2023-02-08 | $5.75M 10-K · filed 2023-02-08 | |
| 2020-09-30 | $4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $7.03M derived: sum of 2 quarters · filed 2021-11-04 | $2.00M 10-Q · filed 2021-11-04 | $3.81M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.05M 10-Q · filed 2021-08-09 | -$240.00K derived: sum of 3 quarters · filed 2022-02-28 | $4.83M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$5.03M 10-Q · filed 2021-05-04 | -$3.22M derived: sum of 2 quarters · filed 2022-02-28 | $1.85M derived: sum of 3 quarters · filed 2022-02-28 | $2.22M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.88M derived: sum of 2 quarters · filed 2022-02-28 | $7.25M derived: sum of 3 quarters · filed 2022-02-28 | $4.07M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $5.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.44M derived: sum of 2 quarters · filed 2020-11-09 | $2.26M 10-Q · filed 2020-11-09 | $3.83M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$2.81M 10-Q · filed 2020-08-05 | -$1.25M derived: sum of 3 quarters · filed 2021-03-01 | $2.55M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$3.18M 10-Q · filed 2020-05-06 | -$1.61M derived: sum of 2 quarters · filed 2021-03-01 | $2.18M derived: sum of 3 quarters · filed 2021-03-01 | $3.15M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.36M derived: sum of 2 quarters · filed 2021-03-01 | $6.32M derived: sum of 3 quarters · filed 2021-03-01 | $4.97M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.76M derived: sum of 2 quarters · filed 2019-11-07 | $3.41M 10-Q · filed 2019-11-07 | $3.75M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$388.00K 10-Q · filed 2019-08-08 | -$43.00K derived: sum of 3 quarters · filed 2020-02-27 | $2.01M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$1.35M 10-Q · filed 2019-05-09 | -$1.01M derived: sum of 2 quarters · filed 2020-02-27 | $1.05M derived: sum of 3 quarters · filed 2020-02-27 | $1.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $2.40M derived: sum of 2 quarters · filed 2020-02-27 | $3.06M derived: sum of 3 quarters · filed 2020-02-27 | $1.92M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $2.71M derived: sum of 2 quarters · filed 2018-11-06 | $1.57M 10-Q · filed 2018-11-06 | $2.16M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $653.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$483.00K 10-Q · filed 2018-08-01 | $106.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.13M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$1.14M 10-Q · filed 2018-05-08 | -$547.00K derived: sum of 2 quarters · filed 2019-02-26 | $474.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.27M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.61M derived: sum of 2 quarters · filed 2019-02-26 | $2.41M derived: sum of 3 quarters · filed 2019-02-26 | $1.12M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.82M derived: sum of 2 quarters · filed 2017-11-09 | $532.00K 10-Q · filed 2017-11-09 | $1.59M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$489.00K 10-Q · filed 2017-08-07 | $573.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.21M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$1.29M 10-Q · filed 2017-05-04 | -$225.00K derived: sum of 2 quarters · filed 2018-02-27 | $413.00K derived: sum of 3 quarters · filed 2018-02-27 | $815.00K derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.70M derived: sum of 2 quarters · filed 2018-02-27 | $2.10M derived: sum of 3 quarters · filed 2018-02-27 | $1.40M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $638.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.04M derived: sum of 2 quarters · filed 2016-11-04 | $337.00K 10-Q · filed 2016-11-04 | $1.06M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$301.00K 10-Q · filed 2016-08-08 | $424.00K derived: sum of 3 quarters · filed 2017-03-09 | $565.00K derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-03-31 | -$703.00K 10-Q · filed 2016-05-06 | $22.00K derived: sum of 2 quarters · filed 2017-03-09 | $163.00K derived: sum of 3 quarters · filed 2017-03-09 | $323.00K derived: sum of 4 quarters · filed 2017-03-09 | |
| 2014-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $866.00K derived: sum of 2 quarters · filed 2017-03-09 | $1.03M derived: sum of 3 quarters · filed 2017-03-09 | $894.00K 10-K · filed 2017-03-09 | |
| 2014-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $301.00K derived: sum of 2 quarters · filed 2015-11-06 | $169.00K 10-Q · filed 2015-11-06 | $263.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | $160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $28.00K 10-Q · filed 2015-08-07 | $122.00K derived: sum of 3 quarters · filed 2016-03-04 | ||
| 2014-03-31 | -$132.00K 10-Q · filed 2015-05-11 | -$38.00K derived: sum of 2 quarters · filed 2016-03-04 | |||
| 2013-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $280.00K 10-K · filed 2016-03-04 | |||
| 2013-09-30 | $186.00K 10-Q · filed 2014-11-12 | ||||
| 2012-12-31 | $51.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |